human immunodeficiency virus單語(yǔ)例句
1. The humanimmunodeficiencyvirus is spread mainly through intravenous drug use and sex.
2. More than 40 million people are infected with the incurable and fatal humanimmunodeficiencyvirus.
human immunodeficiency virus雙語(yǔ)例句
1. DLA-EIAV can be served as the animal model for studying on humanimmunodeficiencyvirus. The vaccine was developed in two stages. A carefully selected field isolate, EIAV LN, was passaged 133 times in vivo in donkeys to generate the highly virulent and pathogenic strain D510, which kills animals within a few weeks. D510 went through 135 passages in vitro to obtain vaccine strains DLV. In order to investigate the molecular mechanism of the attenuation and protection of donkey leukocyte attenuated equine infectious anemia virus, we investigated the evolution of LTR of 24 out of 110 passages during Chinese EIAV attenuation.
馬傳貧弱毒疫苗致弱路線(xiàn)是：將一株來(lái)源于馬體的EIAV 超強毒力的遼毒株經(jīng)過(guò)驢體連續傳代100 余代使病毒毒力增強后獲得了驢強毒株(對馬和驢均100%致死)，然后將DV 株連續通過(guò)驢白細胞進(jìn)行體外培養馴化，使其病毒毒力完全喪失，而保持了良好的免疫原性，最終培育成功EIAV 驢白細胞弱毒疫苗(沈榮顯等，1979)，DLA進(jìn)一步通過(guò)驢胎皮膚細胞培養馴化，又獲得了皮膚細胞弱毒疫苗株。
2. As a inhibitor for neurotropic virus, humanimmunodeficiencyvirus type 1 (HIV-1) invades the brain and causes severe neuronal, astrocyte, and myelin damage in AIDS patients.
作為向神經(jīng)病毒、人免疫缺陷病毒1類(lèi)型(HIV -1)侵入大腦，并且在愛(ài)滋病病患里引起嚴厲的神經(jīng)元、腦和骨髓的星細胞和髓磷脂損害的抑制劑。
3. Detail Contents: Genetic disorders -- Immune deficiencies -- Breast cancer -- Colon cancer -- Melanoma -- Cystic fibrosis -- Hemophilia -- Liver disease -- Cardiovascular disease -- Muscular dystrophy -- Alzheimer's disease -- Parkinson's disease -- Huntington's disease -- Viruses: the cornerstone of gene therapy -- Viruses are living crystals -- Viral genomes may be RNA or DNA -- Viruses evolved from plasmids -- Viruses know how to infect cells -- The virus as a gene vehicle -- Viruses used in gene therapy -- Ashi DeSilva: a promising start -- Clinical trials defined -- Cells of the immune system -- Adenosine deaminase -- Preliminary research -- Clinical procedure for ADA gene therapy -- The DeSilva clinical trial -- Jesse Gelsinger: down to earth -- Ornithine transcarbamylase -- Preliminary research -- Clinical procedure for OTC gene therapy -- The Gelsinger clinical trial -- The investigation -- Concluding remarks -- Future prospects -- Safer vehicles -- Reducing immune rejection of the vector -- Improved risk assessment -- Redesigning human anatomy and physiology -- Ethics of gene therapy -- The Belmont report -- Clinical trials -- Physiological enhancement -- Cosmetic applications -- Legal issues -- Regulatory agencies -- The Gelsinger legal trial -- International regulation -- Resource center -- Eucaryote cell primer -- Recombinant DNA primer -- The human genome project -- X-linked severe combined immunodeficiency (SCID-X1)-- Alzheimer's disease -- Huntington's disease.
細節內容︰遺傳疾病-免疫的缺乏-乳腺癌-結腸癌-黑瘤-囊性纖維變性-血友癥-肝疾病-心血管疾病-肌營(yíng)養不良-早老性癡呆病-帕金森疾病-亨廷頓疾病-病毒︰基礎的基因治療-病毒在活著(zhù)水晶--病毒的基因可能是RNA或者DNA --病毒從plasmids被逐步形成--病毒知道怎樣感染細胞--作為一輛基因車(chē)輛的病毒--基因治療使用的病毒-Ashi DeSilva︰有希望開(kāi)始-臨床試驗確定--細胞的這免疫系統-Adenosine deaminase-初步研究-臨床程式給埃達基因治療--這DeSilva臨床試驗-婕西Gelsinger︰到地球-Ornithine transcarbamylase-初步研究-臨床程式給OTC基因治療-- Gelsinger臨床試驗-調查-達成評論-前景-更安全的車(chē)輛--矢量的降低免疫的拒絕-改進(jìn)風(fēng)險估計-重新設計人解剖學(xué)和生理學(xué)--倫理學(xué)的基因治療-那些貝拉蒙特報告-臨床試驗-生理提升-美容應用-法律問(wèn)題-協(xié)調機構-- Gelsinger 合法審訊-國際管理-資源中心人物-Eucaryote信元第一-Recombinant DNA 入門(mén)--人類(lèi)基因工程-- X 連結的嚴重的結合的免疫缺陷(SCID-X1)-早老性癡呆病--亨廷頓的疾病。
4. It is caused by infection with the HumanImmunodeficiencyVirus.
這是由于感染人體免疫缺陷病毒
5. He said that AIDS is from humanimmunodeficiencyvirus infection.
他介紹說(shuō)，艾滋病是由人類(lèi)免疫缺陷病毒感染引起的。
6. It was later named the humanimmunodeficiencyvirus.
它在后來(lái)被命名為人類(lèi)免疫缺陷病毒。
7.
7. Objective To improve the awareness of humanimmunodeficiencyvirus infection in patients with pulmonary tuberculosis.
目的 提高對人類(lèi)免疫缺陷病毒陽(yáng)性肺結核的認識。
8. More than 80 percent of humanimmunodeficiencyvirus infections are transmitted via sexual intercourse.
80%以上的人類(lèi)免疫缺陷癥感染是通過(guò)性接觸傳遞的。
9. In contrast to previously characterized human oncogenic retroviruses, the novel retrovirus they had discovered, now known as humanimmunodeficiencyvirus, did not induce uncontrolled cell growth.
相較于以往的特點(diǎn)人類(lèi)致癌病毒，新病毒，他們發(fā)現了，現在被稱(chēng)為人類(lèi)免疫缺陷病毒，并沒(méi)有引起不受控制的細胞生長(cháng)。
10. Subject words】 Humanimmunodeficiencyvirus type 1; Drug users; Tetrapeptide on tip of the V3 loop
人類(lèi)免疫缺陷病毒1型；藥癮；V3環(huán)頂端四肽基因序列
11.
11. It is well-known that the mathematical models provise very important information for theresearch of humanimmunodeficiency uirus-type 1 and hepatitis C virus.
在研究人類(lèi)免疫缺陷性病毒HIV和丙肝病毒C中，數學(xué)模型起到了非常重要的作用。
12. Objective To understand the knowledge of pregnant and lying-in women, and related people on humanimmunodeficiencyvirus/acquired immure deficiency syndrome and attitude tO HIV positive pregnant women in Yunnan rural areas.
目的了解云南省農村孕產(chǎn)婦及相關(guān)人群對艾滋病傳播與預防知識知曉水平和對感染人類(lèi)免疫缺陷病毒孕產(chǎn)婦的態(tài)度。
13.
13. The frequency of CMV seronegativity showed a stepwise decrease with the increase of donor age. In addition, the prevalence of HBsAg, antibodies to hepatitis C virus, antibodies to humanimmunodeficiency viruses type 1 and 2 (anti-HIV 1+2) and antibodies to human T-cell lymphotropic viruses type I and II (anti-HTLV 1/11) were compared between CMV seropositive and seronegative groups. Our results showed that there was no significant difference in seroprevalence of these markers between CMV seropositive and seronegative groups.
為了更進(jìn)一步了解巨細胞病毒抗體和其它血液篩檢項目之相關(guān)性，吾人在同批檢體中比較巨細胞病毒抗體陽(yáng)性者和陰性者其 B 型肝炎表面抗原、C型肝炎抗禮、第一型暨第二型人類(lèi)免疫缺乏病毒抗體和第一型暨第二型人類(lèi)嗜 T 淋巴球病毒抗體之陽(yáng)性率，結果發(fā)現這些陽(yáng)性率在兩者間無(wú)有意義之差異。
14. Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in humanimmunodeficiencyvirus infected subjects.
脂肪營(yíng)養障礙和抗逆轉錄病毒治療可以作為人免疫缺陷癥病毒感染受試者的亞臨床動(dòng)脈粥樣硬化的預測器
15. Simian ImmunodeficiencyVirus is very similar to HumanImmunodeficiencyVirus and it is used to study the condition in animal models.
猴免疫缺陷病毒與人免疫缺陷病毒非常相似，被用于動(dòng)物模型的研究。
16. Simian immunodeficiencyvirus to chimpanzees brought significantly less than the harm to humanimmunodeficiencyvirus harm to human beings.
猿類(lèi)免疫缺陷病毒給黑猩猩帶來(lái)的危害要明顯小于人類(lèi)免疫缺陷病毒給人類(lèi)造成的危害。
17. Objective To study the transmission rate and influence factors of humanimmunodeficiencyvirus type 1(HIV1) among the family members with unknown infector.
目的 研究在未知情的情況下，家庭內艾滋病病毒的傳播率及影響因素。
18. 293T cells transfected with ACE2, but not those transfected with humanimmunodeficiencyvirus-1 receptors, formed multinucleated syncytia with cells expressing S protein.
轉染了ACE2的293T細胞能與表達S蛋白的細胞形成多核體，而同樣的293T細胞轉染了人免疫缺陷病毒-1則不行。
19. Chapter 2: investigates peptides in complex with the HumanImmunodeficiencyVirus protease found in the PDB bank, using flexible molecule alignment and molecular docking. Predicts the similarities between the inhibitors and Saquinavir.
第二章：選擇PDB數據庫中HIV蛋白酶復合物為研究對象，通過(guò)分子疊合、分子對接研究，預測出了這類(lèi)抑制劑與已經(jīng)上市的抗艾滋病的藥物Saquinavir之間的相似性和對HIV病毒蛋白酶的不同抑制作用。
20.
20. Objective To observe the inhibitory effect of 1, 2, 6-Tri-O-galloyl-β-D-glucopyranose from Balanophora japonica Makino on humanimmunodeficiencyvirus entry into the host cells and explore the mechanisms.
目的 檢測來(lái)源于蛇菰科植物日本蛇菰中的單體化合物三沒(méi)食子酰吡喃葡萄糖抑制HIV與靶細胞融合的活性，并探討其作用靶點(diǎn)。